Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Patent for rapid gene discovery technology:

This article was originally published in Clinica

Executive Summary

Myriad Genetics has been granted a US patent covering a technology to speed up the discovery of disease-related genes. The method, called "island hopping", is a way of increasing the rate of sequencing large pieces of DNA by automatically selecting single bands, or islands, of DNA. The technology is used by Salt Lake City-based Myriad to highlight genes and proteins with diagnostic and therapeutic potential through its ProNet protein discovery technology. The company licenses the ProNet technology out to pharmaceuticals companies on a non-exclusive basis.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT082132

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel